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Abstract
Background: Bovine leukemia virus (BLV) is associated with enzootic bovine leukosis, which is the most common
neoplastic disease of cattle. BLV infects cattle worldwide, imposing a severe economic impact on the dairy cattle
industry. Recently, we developed a new quantitative real-time polymerase chain reaction (PCR) method using
Coordination of Common Motifs (CoCoMo) primers to measure the proviral load of known and novel BLV variants
in BLV-infected animals. Indeed, the assay was highly effective in detecting BLV in cattle from a range of
international locations. This assay enabled us to demonstrate that proviral load correlates not only with BLV
infection capacity as assessed by syncytium formation, but also with BLV disease progression. In this study, we
compared the sensitivity of our BLV-CoCoMo-qPCR method for detecting BLV proviruses with the sensitivities of
two real-time PCR systems, and also determined the differences of proviral load with serotests.
Results: BLV-CoCoMo-qPCR was found to be highly sensitive when compared with the real-time PCR-based
TaqMan MGB assay developed by Lew et al. and the commercial TaKaRa cycleave PCR system. The BLV copy
number determined by BLV-CoCoMo-qPCR was only partially correlated with the positive rate for anti-BLV antibody
as determined by the enzyme-linked immunosorbent assay, passive hemagglutination reaction, or agar gel
immunodiffusion. This result indicates that, although serotests are widely used for the diagnosis of BLV infection, it
is difficult to detect BLV infection with confidence by using serological tests alone. Two cattle were experimentally
infected with BLV. The kinetics of the provirus did not precisely correlate with the change in anti-BLV antibody
production. Moreover, both reactions were different in cattle that carried different bovine leukocyte antigen
(BoLA)-DRB3 genotypes.
Conclusions: Our results suggest that the quantitative measurement of proviral load by BLV-CoCoMo-qPCR is
useful tool for evaluating the progression of BLV-induced disease. BLV-CoCoMo-qPCR allows us to monitor the
spread of BLV infection in different viewpoint compared with classical serotest.
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Background
Bovine leukemia virus (BLV) is associated with enzootic
bovine leucosis (EBL) [1], which is the most common
neoplastic disease of cattle. Infection by BLV can remain
clinically silent, with cattle in an aleukemic state. Alter-
natively, it can emerge as persistent lymphocytosis (PL),
characterized by an increased number of B lymphocytes,
and, more rarely, as B-cell lymphomas in various lymph
nodes after a long latent period [2]. Sheep that are ex-
perimentally inoculated with BLV develop B-cell tumors
at a higher frequency and with a shorter latent period
than naturally infected cattle [2,3].
BLV is closely related to human T-cell leukemia virus
types 1 and 2 (HTLV-1 and −2), which are associated
with adult T-cell leukemia (ATL) and with the chronic
neurological disorder tropical spastic paraparesis/HTLV-
1-associated myelopathy [2]. Defective HTLV-1 proviral
genomes have been found in more than half of all exam-
ined patients with ATL [4-7]. By contrast, genomic
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Southern hybridization of BLV proviral DNA yielded
only bands that corresponded to the full-size provirus in
all 23 cattle at the lymphoma stage and in all 7 BLV-
infected but healthy cattle [8]. Polymerase chain reaction
(PCR) with primers located in the long terminal repeat
(LTRs) clearly demonstrated that almost the complete
provirus was retained in all 27 cattle with lymphomas
and in all 19 infected but healthy cattle [8]. We previ-
ously performed conventional PCR with various primers
spanning the entire BLV genome to detect even small
defects. The obtained PCR products specifically covered
the entire BLV genome in all 40 of the BLV-infected cat-
tle tested [8]. Therefore, it appears that at least one copy
of the full-length BLV proviral genome was maintained
in each animal throughout the course of the disease.
Moreover, either large or small deletions of proviral gen-
omes may be very rare events in BLV-infected cattle.
The above findings suggest that the BLV provirus
remains integrated in cellular genomes [9,10], even in
the absence of detectable BLV antibodies. After their in-
fection, BLV expression in cattle is blocked at the tran-
scriptional level during the latent period [11]. This
repression appears to be very important in the escape of
BLV from the host immunosurveillance system. Such si-
lencing is also observed in BLV-infected sheep [11,12].
The mechanism responsible for BLV silencing is un-
known. Therefore, in addition to the routine diagnosis of
BLV infection using conventional serological techniques
such as the agar gel immunodiffusion (AGID) [3,13-15]
and enzyme-linked immunosorbent assay (ELISA) [14-17],
diagnostic BLV PCR techniques that aim to detect the inte-
grated BLV proviral genome within the host genome are
also commonly used [8,14-16,18,19].
TaKaRa cycleave PCR was recently developed as a
commercial BLV detection kit targeting the tax region,
which is present at only one copy per provirus, and
encodes a transactivator protein Tax. Lew et al. [20]
reported a method to quantify BLV provirus using real-
time PCR. Their method targets the BLV pol gene, which
is present at only one copy per provirus, and the primer
annealing regions are potentially susceptible to mutation.
We recently developed a new quantitative real-time PCR
(qPCR) method targeting the BLV LTR. This region is
present at two copies per provirus, which contributes to
the improved sensitivity of our assay [21]. To design
degenerate primers addressing BLV diversity, our BLV-
CoCoMo-qPCR method uses the Coordination of Com-
mon Motifs (CoCoMo) algorithm, which was developed
especially for the detection of multiple viral species. The
obtained primers were used to measure the proviral
loads of known and novel BLV variants in clinical ani-
mals. This method was highly effective in detecting a
wide range of mutated BLV viruses in cattle from various
international locations. BLV infects cattle worldwide,
imposing a severe economic impact on the dairy cattle
industry [13-16,22,23]. To normalize the viral genomic
DNA, the BLV-CoCoMo-qPCR technique amplifies a
single-copy host gene, the bovine leukocyte antigen
(BoLA)-DRA gene, in parallel with the viral genomic
DNA. This measurement permits adjustment for varia-
tions in amplification efficiency between samples. Thus,
the assay is specific, sensitive, quantitative, and reprodu-
cible, and is able to detect BLV strains from cattle world-
wide, including those for which previous attempts at
detection by nested PCR have failed. Using this assay, we
previously demonstrated that proviral load correlates not
only with BLV infection capacity as assessed by syncyt-
ium formation, but also with BLV disease progression.
In this study, we compared the sensitivity of our BLV-
CoCoMo-qPCR method for detecting BLV proviruses
with the sensitivities and reproducibilities of two real-
time PCR systems, using an infectious full-length mo-
lecular clone of BLV, pBLV-IF [24]. The sensitivities of
antibody-detection methods such as ELISA, passive
hemagglutination reaction (PHA), and AGID, and the
proviral load estimated by BLV-CoCoMo-qPCR were
estimated in 370 cattle. To analyze the kinetics of the
provirus and relevance of the BLV antibody, two BLV-
negative Holstein-Friesian cattle that carried different
BoLA-DRB3 genotypes were experimentally infected
with BLV, and the titers of serum antibody and proviral
load were measured.
Methods
Animal samples and isolation of genomic DNA and serum
Blood samples were obtained from 48 Japanese black
cattle in herd A and 322 Holstein-Friesian cattle in
herd B. These cattle were all maintained in Japan. For
experimental infection, two BLV-negative one-year-old
Holstein-Friesian cattle were used. Genomic DNAs
for PCR amplification were isolated from EDTA-
treated whole blood samples by using the Wizard
Genomic DNA Purification Kit (Promega Corporation,
Tokyo, Japan). The Sera were separated from blood of
cattle mentioned above.
Detection of BLV provirus by real-time PCR
Real-time PCR was performed with TaqMan Universal
Master Mix II (Life Technologies, Tokyo, Japan) for
BLV-CoCoMo-qPCR [21] and the TaqMan minor groove
binder (MGB) assay developed by Lew et al. [20] or with
the Cycleave PCR system (TaKaRa Bio, Inc, Tokyo,
Japan) on the 7500 FAST Real-time PCR System (Life
Technologies).
The BLV LTR genes were detected by BLV-CoCoMo-
qPCR [21]. In brief, 120-bp of the BLV-LTR gene were
amplified by the CoCoMo6 and CoCoMo81 primer set
and detected with 15 bp of the 6-carboxyfluorescein
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(FAM)-labeled MGB probe. The BLV pol gene was
detected by the TaqMan MGB assay developed by Lew
et al. [20]. Briefly, 67 bp of the BLV pol gene were amp-
lified by the BLVMGBF and BLVMGBR primer set and
detected with 15 bp of the FAM-labeled MGB probe.
The BLV tax gene was detected as suggested by the
manufacturer, using the Cycleave PCR BLV detection kit
(TaKaRa Bio Inc.), which amplified the BLV tax gene
and detected it with the FAM-labeled Cycleave probe.
Evaluation of BLV proviral load by BLV-CoCoMo-qPCR
The proviral load (expressed as the number of copies of
provirus per 100,000 peripheral blood mononuclear cells
[PBMCs]) was evaluated by qPCR on the genomic DNA
for the numbers of copies of LTR and BoLA-DRA [21].
In brief, 30 ng of cattle genomic DNA, which usually
contained 1 x 103 to 3 x 103 copies of BoLA-DRA genes
(0.5 to 1.5 x 103 of cell number), was used for PCR ampli-
fication. BLV copy number were calculated using 10 to 1 x
106 copies of the standard plasmid, which contained the
BLV-LTR region inserted into pBluescript II SK+plasmid.
Each value was calculated in a single experiment.
Detection of BLV provirus by nested PCR
BLV LTR gene was detected by nested PCR, as described
previously [21]. In brief, the first PCR amplification was
performed with the primers BLTRF-YR and BLTRR. The
first PCR amplicons were subsequently applied to the
second PCR, with the 256 and 453 primer set. PCR
amplification was performed with a TGRADIENT ther-
mocycler (Biometra). PCR products were detected by
ethidium bromide staining.
Detection of anti-BLV antibody in serum samples
Anti-BLV antibodies were detected using three detection
systems. The PHA method was performed according to
the manufacturer’s instructions using the Bovine Leuco-
sis Antibody Assay Kit “Nisseiken” (Nisseiken, Tokyo,
Japan). The AGID test for detection of the anti-BLV
antibody was performed according to the manufacturer’s
instructions, using a commercial bovine leukemia virus
antibody test kit (Kitazato, Japan). Finally, ELISA was
performed according to the manufacturer’s instructions,
using an ELISA kit for detecting anti-BLV antibody (JNC
Inc., Tokyo, Japan).
Experimental infection of BLV
Two BLV-negative one-year-old Holstein-Friesian cattle
(SK576 and SK577) were experimentally challenged sub-
cutaneously with 0.5 ml of blood obtained from BLV-
seropositive Japanese Black cattle (16-year-old, normal
lymphocyte count [4,660/μl]). Blood samples (used for
DNA and serum isolation) were collected weekly for
10 weeks after the first inoculation. BLV proviral loads
were measured by BLV-CoCoMo-qPCR. The S/P values
of ELISA were determined by: S/P = [(absorbance of
antigen existence and sample added well)-(absorbance of
antigen absence and sample added well)]/[(absorbance
of antigen existence and positive control added well)-
(absorbance of antigen absence and positive control
added well)]. The dilution ratio of PHA indicates the
observed limit point of hemagglutination.
BoLA-DRB3 typing
BoLA-DRB3 alleles were typed by the PCR-sequence
based typing (SBT) method [25]. In brief, BoLA-DRB3
exon 2 was amplified by the DRB3FRW and DRB3REV
primer set by single-step PCR, and the nucleotide
sequences were subsequently determined. Sequence data
were analyzed by ASSIGN 400 ATF software (Conexio
Genomics, Fremantle, Australia), and both BoLA-DRB3
alleles of the cattle were determined.
Results
A comparison of the sensitivity and the reproducibility
of BLV-CoCoMo-qPCR to those of other TaqMan real-
time PCR methods for the detection of the BLV
provirus.
We compared the sensitivity and the reproducibility
of the BLV-CoCoMo-qPCR method with those of two
real-time PCR systems for BLV provirus detection: the
TaqMan MGB assay developed by Lew et al. [20], and
the commercial TaKaRa cycleave PCR assay. This ex-
periment was performed with an infectious full-length
molecular clone of BLV, pBLV-IF [24] (Table 1).
Table 1 Comparison of BLV proviral detection by







(copy number) Cycleave PCRc
100 3/3d 3/3 3/3
50 3/3 3/3 3/3
25 3/3 3/3 3/3
12.5 3/3 3/3 3/3
6.25 3/3 3/3 3/3
3.125 3/3 3/3 3/3
1.5625 3/3 0/3 3/3
0.78125 3/3 0/3 2/3
0 0/3 0/3 0/3
a BLV LTR genes were detected by BLV-CoCoMo-qPCR (Jimba et al., 2010).
b BLV pol gene was detected by TaqMan MGB assay developed by Lew et al.
(Lew et al., 2004).
c BLV tax gene was detected by the cycleave PCR BLV detection kit (TaKaRa
Bio inc.).
d Number detected per number tested.
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To determine the sensitivity, we performed a 2-fold di-
lution of pBLV-IFconc and multifold dilutions of pBLV-
LTRconc to give a range of provirus copy numbers from
100 to 0.78125, and examined after triplicate PCR ampli-
fications the percentage of successful amplification. All
of the amplifications obtained by the three methods suc-
cessfully detected BLV-IF when it was present at ≥3.125
copies. The sensitivities of the three real-time PCR
methods for the detection of pBLV-IF differed when
≤1.5625 copies of the provirus was employed. The BLV-
CoCoMo-qPCR and TaKaRa cycleave PCR methods, but
not the TaqMan MGB assay developed by Lew et al. suc-
cessfully detected pBLV-IF with 1.5625 copies of pro-
virus at a rate of 100%. With 0.78125 copies of the
pBLV-IF provirus, the detection rate was significantly
lower with the TaqMan MGB assay developed by Lew
et al. (0%), but BLV-CoCoMo-qPCR (100%) and TaKaRa
cycleave PCR (66.7%) resulted in high and moderate de-
tection rates. Together, these results indicate that, at low
proviral loads of pBLV-IF, the sensitivity of BLV-
CoCoMo-qPCR is better than those of the TaqMan
MGB assay developed by Lew et al. and the TaKaRa
cycleave PCR assay.
Next, we evaluated the reproducibility of the copy
numbers obtained by the three methods (Figure 1). At
low copies numbers, the copy number determined by
CoCoMo-qPCR was the most reproducible (R2 = 0.93744),
the copy number determined by TaKaRa cycleve PCR was
moderately reproducible (R2 = 0.85754), and the copy
number detected by the TaqMan MGB assay developed by
Lew et al. was the least reproducible (R2 = 0.39447). These
results clearly demonstrated that this assay has good
reproducibility.
Thus, it appeared that BLV-CoCoMo-qPCR was the
most suitable method for estimating BLV proviral load.
Comparison of BLV-CoCoMo-qPCR with nested PCR and
serological tests
We compared the sensitivity of BLV-CoCoMo-qPCR
with those of nested PCR and conventional serological
techniques, including AGID, PHA, and ELISA, using
370 clinical samples from two farms in Japan (Table 2
and Figure 2).
A total of 39 out of 370 cattle were negative for BLV
provirus and anti-BLV antibody, as determined by the four
methods. A total of 150 out of 370 cattle were negative for
BLV provirus, as determined by both BLV-CoCoMo-qPCR
and nested PCR. However, some animals that were nega-
tive for proviral load, as determined by BLV-CoCoMo-
qPCR, were positive in the serological tests. For example,
75 of 160 samples (46.9%) were positive by PHA, 25 of
163 samples (15.3%) were positive by AGID, and 94 of 151
samples (62.3%) were positive by ELISA.
Furthermore, a total of 56 out of 370 cattle were posi-
tive for BLV provirus and anti-BLV antibody, as deter-
mined by all five methods. A total of 161 out of 370
cattle were positive for BLV provirus, as determined by
both BLV-CoCoMo-qPCR and nested PCR. By contrast,
a total of 22 out of 183 cattle (12.0%) were positive for
BLV provirus by BLV-CoCoMo-qPCR but were negative
in the nested PCR assay. However, the positive rate for
nested PCR was 100% in animals with proviral loads of
>1,500 copies per 105 cells, indicating that the positive
rate for nested PCR in animals correlated well with the
level of proviral load determined by BLV-CoCoMo-qPCR.
Moreover, some animals that were positive for proviral
load, as determined by BLV-CoCoMo-qPCR were positive
in the serological tests: 127 of 199 samples (63.8%) were
positive by PHA, 181 of 207 samples (87.4%) were positive
by AGID, and 152 of 154 samples (98.7%) were positive by
ELISA.
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Figure 1 Sensitivity and reproducibility of each real-time PCR method using a pBLV-IF. The copy number of pBLV-IF was determined by
calculation and TaKaRa Cycleave PCR. One hundred copy of pBLV-IF was diluted 2-fold to construct the standard curve. Threshold values (Ct)
were plotted against corresponding pBLV-IF copy numbers and the correlation coefficient (R2) was determined. The experiments were run in
duplicate and independently repeated three times with the same dilutions. pBLV-IF standard curves were generated by using the results of
CoCoMo-qPCR (A), the TaqMan MGB assay developed by Lew et al. (B), and TaKaRa Cycleave PCR (C).
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Table 2 Comparison of BLV detection methods using 370
cattle
(a) Copy number/105 cells by BLV-CoCoMo-qPCR = 0
Animal no. Copy numbera Nested PCR PHAb AGIDc ELISAd
1-39 0 -e - - -
40-53 0 - +f - -
54-85 0 - - - +
86 0 - - + -
87-123 0 - + - +
124-129 0 - - + +
130-138 0 - + + +
139-141 0 - - + NTg
142 0 - NT - -
143 0 - NT - +
144 0 - NT - NT
145-148 0 - + - NT
149,150 0 - + + NT
151,152 0 NT - - +
153 0 NT - + +
154 0 NT + - -
155 0 NT + + NT
156 0 NT + - NT
157-159 0 NT + - +
160,161 0 NT + + +
162 0 + - - +
163 0 + + - -
- 163 150 85 138 57
+ 0 2 75 25 94
Tested 163 152 160 163 151
(b) Copy number/105 cells by BLV-CoCoMo-qPCR > 0
164 1 - + + +
165 1 + + - +
166 1 - - - -
167 2 + - + +
168 3 + + + +
169 3 NT + - +
170 4 + - + +
171 5 - + - -
172 6 + + + NT
173 8 + + - +
174 9 - + - +
175 9 + - - +
176 9 NT + + NT
177 10 + - + +
178 12 + + + +
179 15 + - + NT
Table 2 Comparison of BLV detection methods using 370
cattle (Continued)
180,181 16,17 + - + +
182 17 + + + +
183 17 NT + + +
184 18 - + + +
185 19 + - + +
186,187 20,21 - + + +
188 22 + - + +
189 23 - - - +
190 25 + + + +
191 27 - - + +
192 33 + - + +
193 37 - - + +
194 39 - + + +
195 40 - + + NT
196 41 + - + +
197 42 + + + +
198,199 43,44 + - + +
200 45 - + - +
201 49 + + + +
202 50 - + + +
203 53 + + + +
204 55 NT + + +
205 58 - + + +
206 67 + + + +
207 68 NT - + +
208–210 71,74,79 + + + +
211 83 - NT + +
212 85 + - + +
213 91 NT - + +
214,215 92,96 + + + NT
216 99 - - + +
217 110 + + - +
218 110 - - + +
219 110 + + + NT
220 145 + + - +
221 145 + + + +
222 149 - - + +
223 154 + NT + NT
224 166 + + + +
225 166 + - + NT
226 176 NT - + +
227 176 + + - +
228 180 - + + NT
229,230 190,194 + + + NT
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Table 2 Comparison of BLV detection methods using 370
cattle (Continued)
231 202 NT + + +
232 203 + + + +
233 231 + - - +
234 254 + + + +
235 261 + + - +
236 265 + NT + +
237 270 + + + +
238 295 + - + +
239 321 + + + NT
240 347 + + + +
241 349 NT + + +
242,243 363,366 + + + +
244 374 + - + +
245 472 + + - +
246 475 + + + NT
247 491 + + - +
248 565 - - + +
249 605 + + + NT
250 634 - + + +
251,252 664,684 + - + +
253,254 705,710 + + + +
255-257 835,868,875 + - + +
258 876 + + + +
259 942 + - + NT
260,261 1088,1170 + - + +
262 1196 + + + NT
263 1219 + - + +
264,265 1223,1225 + + + +
266 1233 - - - NT
267,268 1279,1282 + - + +
269 1445 + NT + +
270 1459 + + + NT
271 1495 + - + +
272,273 1501,1567 + + + +
274 1648 + - + +
275 1671 + + + +
276 1793 + + + NT
277 1844 + - + NT
278 1902 + + + NT
279 2068 + - + +
280-282 2130,2142, 2183 + + + +
283 2218 - NT + +
284 2219 + - + +
285 2326 + NT + +
Table 2 Comparison of BLV detection methods using 370
cattle (Continued)
286 2338 + + + +
287 2524 + + - +
288 2616 + + + NT
289,290 2621,2727 + + + +
291 2849 NT + + +
292 2855 + - + +
293 2963 + + + +
294 3062 + - + +
295,296 3097,3192 + + + +
297 3294 + + + NT
298 3512 NT + + +
299 3619 NT + + NT
300 3833 + - + +
301 3859 NT - + NT
302 3871 + + + +
303 3955 + + + +
304 4291 + - + NT
305 4517 + + + +
306 4623 NT - + +
307,308 4774,4837 + + + +
309,310 5079,5291 + + + NT
311 5296 NT - - NT
312 5453 + + + NT
313 5490 + - + NT
314,315 5551,5667 + + - +
316 5821 + + + +
317,318 6188,6423 + - + NT
319 6471 NT + + +
320 6567 + + + +
321 6686 + - + +
322 7127 + + + +
323 7303 + - + NT
324 7371 + + - +
325 7376 + NT + +
326 7665 + - + +
327 7835 + + + NT
328 7903 + - + +
329 8879 + + + NT
330 9048 + - + +
331,332 9275,9358 + + + +
333 9417 + - + NT
334,335 9843,10154 + + + NT
336 10252 + + - +
337 10363 NT + + +
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Figure 2A shows the proviral loads of samples that
were either negative or positive by nested PCR, PHA,
AGID, and ELISA. A total of 163 cattle were positive for
BLV LTR sequences as determined by nested PCR, with
copy numbers ranging from 0 to 42,015 copies per 105
cells (mean 5,135 copy). By contrast, 22 cattle were
Table 2 Comparison of BLV detection methods using 370
cattle (Continued)
338 11874 + - - +
339 12040 NT - + NT
340 12461 + - + +
341 12667 + + + NT
342 12791 + - + +
343,344 13136,13229 + + + +
345 13379 + - + +
346 13904 + + + +
347 14057 + + + NT
348 14433 + + + +
349 15602 NT - + +
350 15747 + - + NT
351 15982 + NT + +
352 16099 + + + +
353 16220 NT + + +
354 16984 + + + +
355 17577 + + + NT
356 18419 + + + +
357 18624 NT + + NT
358 19043 NT + + +
359-361 19732,21744 25912 + + + +
362 26883 + - + NT
363 27719 NT + + NT
364 28154 + + + NT
365 28934 + + - +
366 30098 + - + NT
367 32909 + + - +
368,369 36753,42015 + + + NT
370 52680 NT - + NT
- 0 22 72 26 2
+ 208 161 127 181 152
Tested 208 183 199 207 154
aCopy number/105cells by BLV-CoCoMo-qPCR.
bPHA, Passive hemagglutination antigen method performed with the Bovine
Leucosis antibody assay kit “Nisseiken”.
cAGID, Agarose gel Immuno-diffusiontest was also performed for anti-BLV
antibody detection with a commercial bovine leukemia virus antibody test kit.
dELISA, Enzyme-linked immunosorbent assay was performed with an ELISA kit
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Figure 2 Comparison of BLV detection by BLV-CoCoMo-qPCR,
nested PCR, and serological tests. (A) BLV proviral load, as
evaluated by BLV-CoCoMo-qPCR, in whole blood from 370 cattle
that were either positive (+) or negative (−) for BLV LTR sequences,
as determined by nested PCR, and serological tests such as the
passive hemagglutination reaction (PHA), agar gel Immunodiffusion
(AGID) and enzyme-linked immunosorbent assay (ELISA). Bars show
the median BLV proviral load values. The actual number of cattle
that were positive by BLV-CoCoMo-qPCR alone per number of cattle
that were either positive (+) or negative (−) for BLV infection as
determined by each test is indicated at the upper of each block. (B)
Nested PCR positive rates for different proviral copy numbers per
105 cells (copy number of 0-105), as evaluated by BLV-CoCoMo-
qPCR. The positive rate was 1.3 % when the proviral load was 0.
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negative by nested PCR but were positive by BLV-
CoCoMo-qPCR, with proviral loads ranging from 0 to
1,233 copies per 105 cells (mean 20 copy). A total of 202
samples were positive for anti-BLV antibody as deter-
mined by PHA, with copy numbers ranging from 0 to
42,015 copies per 105 cells (mean 3,427 copies). By con-
trast, 157 cattle were negative for anti-BLV antibody as
determined by PHA but were positive as determined by
BLV-CoCoMo-qPCR, with proviral loads ranging from 0
to 52,680 copies per 105 cells (mean 2,049 copies). A
total of 206 samples were positive for anti-BLV antibody
by AGID, with copy numbers ranging from 0 to 52,680
copies per 105 cells (mean 4,516 copies). By contrast,
164 cattle were negative for anti-BLV antibody by AGID
but positive by BLV-CoCoMo-qPCR, with proviral loads
ranging from 0 to 32,909 copies per 105cells (mean 693
copies). A total of 246 samples were positive for anti-
BLV antibody by ELISA, with copy numbers ranging
from 0 to 32,909 copies per 105 cells (mean 2,380 cop-
ies). By contrast, 59 cattle were negative for anti-BLV
antibody by ELISA but positive by BLV-CoCoMo-qPCR,
with proviral loads ranging from 0 to 5 copies per 105
cells (mean 0.1 copies). Moreover, Figure 2A indicated
that the proportion of animals that was negative for
anti-BLV antibodies by serological tests but positive by
BLV-CoCoMo-qPCR was higher than the proportion
that was negative for provirus detection by nested PCR
but positive by BLV-CoCoMo-qPCR. These results
clearly demonstrate that the number of animals that
were positive for the BLV antibody by the three sero-
logical tests did not correlate with the proviral loads
determined by BLV-CoCoMo-qPCR.
We next calculated the positive rate for the nested
PCR method in animals with BLV proviral copy numbers
of 0 to 105 per 105 cells, as evaluated by BLV-CoCoMo-
qPCR (Figure 2B). The proviral copy numbers of 152
samples were estimated to be “0” by BLV-CoCoMo-
qPCR. Two of the 152 samples (1.3%) were positive, but
150 samples (98.7%) were negative for BLV LTR by
nested PCR. Positive rates for the nested PCR ranged
from 62.9% to 98.5% among animals with proviral copy
numbers ranging from 100 to 104 copies per 105 cells.
The positive rate for nested PCR was 100% in animals
with high proviral loads (>104 copies per 105 cells).
Thus, the positive rate for the nested PCR in animals
correlated well with the level of proviral load determined
by BLV-CoCoMo-qPCR.
Kinetics of proviral load and detection of antibodies in
cattle experimentally infected with BLV
Our results showed an inconsistency between the pro-
viral load as evaluated by BLV-CoCoMo-qPCR and the
detection of BLV infection by serological tests. To inves-
tigate the reasons for these different results, two cattle
were experimentally infected with BLV, and the anti-BLV
antibody titer in the serum and proviral load were exam-
ined (Figure 3). Polymorphisms in BoLA class II genes
are responsible for the outcomes of infectious diseases
such as neosporosis, Lone Star tick, clinical mastitis, and
enzootic bovine leukosis [26-30]. Therefore, the two
cattle (SK576 and SK577) were genotyped for BoLA-
DRB3 alleles by the PCR-SBT method. SK576 carried
alleles DRB3*0101/1201, and SK577 carried alleles
DRB3*14011/1201.
We evaluated the number of BLV-infected cells in the
two cattle by BLV-CoCoMo-qPCR from 1 to 10 weeks
after experimental infection with BLV, and compared the








































Figure 3 Proviral load and antibody titer in two experimentally challenged cattle. Two BLV-negative one-year-old Holstein-Friesian cattle
(K576 and K577) were experimentally challenged subcutaneously with 0.5 ml of blood obtained from BLV-seropositive Japanese Black cattle.
Blood and serum samples were obtained weekly for 10 weeks after the first inoculation with infected blood. BLV proviral loads were measured by
BLV-CoCoMo-qPCR. Anti-BLV antibodies were detected by PHA and ELISA. Graphical representations of proviral load, ELISA S/P values, and PHA
titer are shown.
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In Figure 3, the titers indicate the reverse of the serum
dilution for which 50% inhibition of PHA was observed.
The ELISA S/P values were measured for 10 weeks. In
SK577, although the BLV copy number was maintained
at low levels for 10 weeks after BLV challenge, the ELISA
S/P values increased gradually throughout the experi-
mental period after 5 weeks. The PHA titer reached a
peak at 5 weeks after BLV challenge and then decreased.
In SK576, the BLV copy number per 105 cells increased
gradually throughout the experimental period. The
ELISA S/P value started to increase gradually at 5 weeks,
and the value remained high for the experimental
period. Interestingly, the PHA titer was lower at the high
viral load stage and was higher at the low viral load
stage.
Discussion
Recently, we developed the BLV-CoCoMo-qPCR system
to detect various BLV strains with broad geographical
origins. Proviral load determined in this manner was
found to correlate not only with BLV infection capacity
as assessed by syncytium formation, but also with BLV-
induced disease progression. The analyses described here
show that the BLV-CoCoMo-qPCR method is a useful
tool for evaluating BLV infection status. Conventional
serological techniques, including AGID, PHA, and
ELISA, are commonly used to diagnose BLV infection in
Japan. Especially, the AGID test is currently a “golden
standard” for determining BLV infection in Japan. We
demonstrated that animals that were BLV-positive, as
determined by the serological test (46.9% for PHA,
15.3% for AGID, and 62.3% for ELISA), were negative
for proviral load, as determined by BLV-CoCoMo-qPCR
(Table 2 and Figure 2). Furthermore, the sensitivity and
reproducibility of BLV-CoCoMo-qPCR were greater than
those of two previously developed real-time PCR meth-
ods (the TaqMan MGB assay developed by Lew et al.
and the commercial TaKaRa cycleave PCR kit), using an
infectious full-length molecular clone of BLV, pBLV-IF
[24]. Moreover, the proportion of 370 cattle that were
positive for anti-BLV antibody by the three serological
tests was partially correlated with the proviral load
determined by BLV-CoCoMo-qPCR. This result was
confirmed by the finding that the kinetics of the proviral
load did not quite correlate with changes in anti-BLV
antibody production in two cattle experimentally
infected with BLV. Collectively, these results suggest that
the quantitative measurement of proviral load by BLV-
CoCoMo-qPCR is a useful for monitoring the spread of
BLV. In addition, the results show that serological and
genomic tests complement each other and result in cor-
rect detection of BLV-infected cattle.
Whereas the positive detection ratefor nested PCR
correlated well with the proviral load determined by
BLV-CoCoMo-qPCR, the rates of animals that were
positive for anti-BLV antibody by the three serological
test did not correlate with the proviral load (Figure 2A).
This finding indicates an inconsistency between the pro-
viral load determined by BLV-CoCoMo-qPCR and the
detection of BLV infection by serological tests. High
positive rates for each serotest were observed in animals
that were negative in BLV-CoCoMo-qPCR (Table 2 and
Figure 2A). One possible explanation is that SK577,
which was experimentally infected with BLV, produced
antibodies against BLV but had a very low copy number
of BLV throughout the experimental period (Figure 3).
We previously reported that BLV-infected cattle retain a
full-length proviral genome throughout the course of the
disease [8]. Another in vivo dynamic study indicated that
the turnover rate of infected cells is higher in BLV-
infected sheep [31]. Based on the present data and previ-
ous results, we speculate that BLV-infected cells that ex-
press viral genes are eliminated by a strong anti-viral
immune response; however, this would allow the cells
that escape host immunity to survive, resulting in per-
sistence of the virus in those cells throughout lifespan of
the animal. Alternatively, it may be that BLV does not
accumulate only in the peripheral blood used for BLV-
CoCoMo-qPCR, but also in organs. We observed that
numerous cattle that were negative for anti-BLV anti-
body by each serotest (72 animals for PHA, 26 animals
for AGID, and 2 animals for ELISA) were positive for
the provirus as determined by BLV-CoCoMo-qPCR
(Figure 2). This result indicates that it is difficult to detect
BLV infection by using the serological test alone. BLV
infections without the detection of BLV antibodies by
serological tests have been observed previously [32-36].
Thus, this result showed that, when viral gene expression
is very low in BLV-infected cells, the infected cells can es-
cape the immune response and survive, without evoking
an immune response by viral protein production.
An advantage of the BLV-CoCoMo-qPCR method is
that it uses degenerate primers designed from 52 indi-
vidual BLV LTR sequences identified from 356 BLV
sequences in GenBank. It also uses the CoCoMo algo-
rithm that was developed specifically for the detection of
multiple viral species [21]. It is possible that the degen-
eracy of the CoCoMo primers could be too high, which
would reduce the concentration of primers specific for a
particular target sequence and decrease the sensitivity of
the assay. However, this issue did not arise in the present
study: despite the use of degenerate primers, the sensi-
tivity and reproducibility of BLV-CoCoMo-qPCR were
greater than that of two previously developed real-time
PCR methods (i.e., TaqMan MGB which was developed
by Lew et al. and TaKaRa cycleave PCR) (Table 1 and
Figure 1), as follow reasons. 1) To improve the sensitiv-
ity of our assay, we selected BLV-LTR (which is present
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at two copies per provirus) as the target of CoCoMo-
qPCR. In contrast, TaqMan MGB developed by Lew
et al. and TaKaRa cycleave PCR target the BLV pol and
tax gene, respectively, which are present at only one
copy per provirus. 2) The TaqMan probe was used to
improve the sensitivity and specificity and to counter
any drawbacks associated with high degeneracy. Import-
antly, the sequence of the BLV TaqMan probe, located
between positions corresponding to two of the CoCoMo
primers, was completely conserved among the 52 BLV
variants. 3) A preliminary experiment demonstrated that
the primer annealing regions of the TaqMan MGB assay
developed by Lew et al. were variable in 10% of the 78
pol sequences selected from GenBank (on 2nd October,
2010). This finding indicates that it is difficult to detect
all of these variants. By contrast, use of degenerate pri-
mers allows for the detection of BLV sequence variants,
including those that arise from mutations. Indeed, we
previously demonstrated that this method can detect
various BLV strains of broad geographical origins, in-
cluding Japan, Peru, Bolivia, Chile, and the U.S.A. [21].
In the present study, we found that the propagation of
and immunoresponses to BLV were different in two cat-
tle that carried different BoLA-DRB3 genotypes. This ex-
periment may help direct future research into examining
whether or not progression of BLV-induced diseases cor-
relates with not only viral propagation, but also with
host factors that are associated with the immune re-
sponse. We previously reported that, in sheep experi-
mentally infected with BLV, quantitative and/or
qualitative aspects of the immunoresponse, production
of neutralizing antibodies against BLV, and elimination
of BLV depended on the particular allelic forms of the
MHC class II molecules expressed by an individual and,
in particular, on certain polymorphic amino acid resi-
dues in class II molecules [37,38]. Additional studies
are required to define the mechanism of association
between BLV-induced disease progression and MHC
polymorphism.
Using BLV-CoCoMo-qPCR, we previously found an in-
crease in the proviral load during disease progression
[21]. This result strongly suggests that proviral load may
be an excellent indicator for monitoring disease progres-
sion and for implementing segregation programs to
minimize BLV transmission. One advantage of the pro-
viral load measurement is that it can be used to follow the
dynamics of BLV-infected cells in vivo. However, in the
current study, proviral load was only determined in cell
populations from peripheral blood. Because transformed
phenotype of target lymphocytes for BLV is CD5+-B cells
[39], it is easy to imagine that the proviral load in periph-
eral blood increases with disease progression. However,
BLV can infect not only B cells, but also many other cell
populations. It is still unknown which peripheral blood or
organs maintain the BLV proliferation. In cattle harboring
anti-BLV antibodies but lacking detectable BLV provirus
in the blood, BLV may accumulate not only in the periph-
eral blood but also in organs. On the other hand, in cattle
showing detectable BLV provirus in peripheral blood but
lacking anti-BLV antibodies, BLV gene expression may be
strongly suppressed. The BLV-CoCoMo-qPCR method
can be used to investigate the mechanism by which BLV
persists in vivo, by analyzing which organ is the key com-
ponent in the maintenance of BLV proliferation.
Conclusions
Recently, we developed the BLV-CoCoMo-qPCR system
to detect various BLV strains with broad geographical
origins. The BLV-CoCoMo-qPCR method is a useful tool
for evaluating the progression of BLV-induced disease.
In this study, BLV-CoCoMo-qPCR was found to be
highly sensitive when compared with the real-time
PCR–based TaqMan MGB assay developed by Lew et al.
and the commercial TaKaRa cycleave PCR system. We
observed that numerous cattle that were negative for
anti-BLV antibody by each serotest were positive for the
provirus as determined by BLV-CoCoMo-qPCR. By con-
trast, numerous animals that were BLV-positive by the
serological test showed a negative proviral load by BLV-
CoCoMo-qPCR. This result was confirmed by the find-
ing that the kinetics of the proviral load did not quite
correlate with changes in anti-BLV antibody production
in two cattle experimentally infected with BLV. This re-
sult indicates that it is difficult to detect BLV infection
by using the serological test alone. Collectively, these
results suggest that the quantitative measurement of
proviral load by BLV-CoCoMo-qPCR is a useful for
monitoring the spread of BLV.
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